ÀǾàǰ ±ÔÁ¦È¯°æ ½ÃÀåÁ¶»çº¸°í¼­

½ÂÀÎ ÀýÂ÷, ÀÓ»ó °¡À̵å¶óÀÎ, °¡°Ý Á¤Ã¥¿¡ °üÇÑ Á¤º¸¸¦ Æ÷ÇÔÇØ ±ÔÁ¦ ÇÁ·Î¼¼½º ¹× ÀÇ·áºñ »óȯ¿¡ ´ëÇÑ ±¹°¡º° º¸°í¼­¸¦ Á¦°øÇÕ´Ï´Ù. º¸°í¼­¿¡´Â ÀǾàǰ ¹× ÀÇ·á±â±â¿¡ ÃÊÁ¡À» ¸ÂÃá ³»¿ëÀÌ °ÔÀçµÇ¾î ÀÖ½À´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû ȯ°æÀÌ Á¦¾à±â¾÷¿¡°Ô ¹ÌÄ¡´Â ¿µÇâ°ú Á¦¾à »ê¾÷ÀÇ ¹Ì·¡¿¡ ´ëÇØ¼­µµ ´Ù·ç°í ÀÖ½À´Ï´Ù.

1 - 25 (Àüü: 40°Ç)
¼¼°èÀÇ ¾à¹° °¨½Ã ¼ÒÇÁÆ®¿þ¾î ½ÃÀå(2025-2033³â)
Global Pharmacovigilance Software Market - 2025-2033
¹ßÇà 2025³â 03¿ù
°¡°Ý US $ 4,350 £Ü 6,282,000 (ºÎ°¡¼¼ º°µµ)
¾à¹°°¨½Ã(PharmaCovigilances) ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼® : ¼ö¸íÁֱ⺰, À¯Çüº°, ¹èÆ÷º°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° - »ê¾÷ ¿¹Ãø(2025-2032³â)
PharmaCovigilances Market Size, Share, and Growth Analysis, By Life Cycle (Pre-clinical, Phase I), By Type (Spontaneous Reporting, Intensified ADR Reporting), By Deployment, By End User, By Region - Industry Forecast 2025-2032
¹ßÇà 2025³â 03¿ù
°¡°Ý US $ 5,300 £Ü 7,654,000 (ºÎ°¡¼¼ º°µµ)
µ¿¹°¿ë ¾à¹°°¨½Ã ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­(2025-2030³â) : ¼Ö·ç¼Çº°, À¯Çüº°, Á¦Ç° À¯Çüº°, µ¿¹° À¯Çüº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø
Veterinary Pharmacovigilance Market Size, Share & Trends Analysis Report By Solution (Software, Services), By Type (In-house), By Product (Anti-Infective) By Animal Type (Dogs, Cats), By Region, And Segment Forecasts, 2025 - 2030
¹ßÇà 2025³â 02¿ù
°¡°Ý US $ 5,950 £Ü 8,593,000 (ºÎ°¡¼¼ º°µµ)
¾à¹°°¨½Ã ½ÃÀå : ÀÓ»ó½ÃÇè ´Ü°èº°, ¹æ¹ý À¯Çüº°, ¼­ºñ½º Á¦°ø¾÷ü À¯Çüº°, Áö¿ªº°
Pharmacovigilance Market, By Clinical Trial Phases, By Type of Method, By Type of Service Provider, By Geography
¹ßÇà 2025³â 02¿ù
°¡°Ý US $ 4,500 £Ü 6,499,000 (ºÎ°¡¼¼ º°µµ)
Á¾¾çÇÐ ºÐ¾ßÀÇ °¡°Ý Ã¥Á¤ ¹× ȯ±Þ¿¡ ´ëÇÑ ÁöºÒÀÚ °ßÇØ
Payer Views on Pricing and Reimbursement in Oncology
¹ßÇà 2025³â 02¿ù
°¡°Ý US $ 8,000 £Ü 11,554,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀÇ·áºñ ȯ±Þ ½ÃÀå(2024-2031³â) : ½ÃÀå ±Ô¸ð, Á¡À¯À² ¹× µ¿Ç⠺м®(û±¸º°, ¼­ºñ½º Á¦°ø¾÷üº°, ÁöºÒÀÚº°), Áö¿ªº° Àü¸Á ¹× ¿¹Ãø
Global Healthcare Reimbursement Market Size, Share & Trends Analysis Report By Claim (Underpaid and Full Paid), By Service Provider, By Payer (Public Payers and Private Payers), By Regional Outlook and Forecast, 2024 - 2031
¹ßÇà 2025³â 02¿ù
°¡°Ý US $ 3,600 £Ü 5,199,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀÇ·áºñ ȯ±Þ ½ÃÀå
Healthcare Reimbursement
¹ßÇà 2025³â 01¿ù
°¡°Ý US $ 5,850 £Ü 8,449,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¼±ÅÃÀû ÀÇ·á ¼­ºñ½º ½ÃÀå º¸°í¼­(2024³â)
Elective Healthcare Services Global Market Report 2024
¹ßÇà 2024³â 12¿ù
°¡°Ý US $ 5,000 £Ü 7,221,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¾à¹°°¨½Ã¿Í ÀǾàǰ ¾ÈÀü¼º ¼ÒÇÁÆ®¿þ¾î ½ÃÀå º¸°í¼­(2024³â)
Pharmacovigilance And Drug Safety Software Global Market Report 2024
¹ßÇà 2024³â 12¿ù
°¡°Ý US $ 5,000 £Ü 7,221,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¾à¹°°¨½Ã ½ÃÀå
Pharmacovigilance
¹ßÇà 2024³â 11¿ù
°¡°Ý US $ 5,850 £Ü 8,449,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¾à¹°°¨½Ã ¹× ÀǾàǰ ¾ÈÀü¼º ¼ÒÇÁÆ®¿þ¾î ½ÃÀå - ±Ô¸ð, Á¡À¯À² : ¼ºÀå ºÐ¼®, ±â´Éº°, Àü°³ ¸ðµåº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° »ê¾÷ ¿¹Ãø(2024-2031³â)
Pharmacovigilance and Drug Safety Software Market Size, Share, Growth Analysis, By Functionality, By Deployment Mode, By End User, By Region - Industry Forecast 2024-2031
¹ßÇà 2024³â 11¿ù
°¡°Ý US $ 5,300 £Ü 7,654,000 (ºÎ°¡¼¼ º°µµ)
¾à¹°°¨½Ã ¹× ÀǾàǰ ¾ÈÀü¼º ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : Á¦Ç°, ÀÓ»ó½ÃÇè, À¯Åë, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Pharmacovigilance & Drug Safety Software Market by Product (Adverse Event Reporting Software, Drug Safety Audits Software, Fully Integrated Software), Clinical Trial (Phase I, Phase II, Phase III), Distribution, End User - Global Forecast 2025-2030
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 3,939 £Ü 5,689,000 (ºÎ°¡¼¼ º°µµ)
¾à¹°°¨½Ã ½ÃÀå : À¯Çü, ÀÓ»ó½ÃÇè, ±â´É, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Pharmacovigilance Market by Type (Contract Outsourcing, In-house), Clinical Trial (Phase I, Phase II, Phase III), Function, End-User - Global Forecast 2025-2030
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 3,939 £Ü 5,689,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀÇ·á »óȯ ½ÃÀå : û±¸, ÁöºÒÀÚ, ¼­ºñ½º Á¦°ø¾÷üº° ¿¹Ãø(2025-2030³â)
Healthcare Reimbursement Market by Claim (Fully Paid, Underpaid), Payer (Private Payers, Public Payers), Service Provider - Global Forecast 2025-2030
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 3,939 £Ü 5,689,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀǾàǰ ¾ÈÀü¼º ½ÃÀå : ±â´É, Àü´Þ ¸ðµå, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)
Drug Safety Market by Functionality (ADR Reporting, Drug Safety Audits, Fully Integrated Software), Delivery Mode (On-Demand, On-Premise), End User - Global Forecast 2025-2030
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 3,939 £Ü 5,689,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¾à¹°°¨½Ã ½ÃÀå(2024-2028³â)
Global Pharmacovigilance Market 2024-2028
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 2,500 £Ü 3,610,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¾à¹°°¨½Ã ¹× ÀǾàǰ ¾ÈÀü¼º ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, Áö¿ªº° Á¡À¯À², µ¿Çâ, ¼ºÀå ±âȸ ºÐ¼® º¸°í¼­ - Á¦°øº°, Àü°³º°, ±â¾÷ ±Ô¸ðº°, Çüź°, ±â´Éº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°
Pharmacovigilance and Drug Safety Software Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Offering, Deployment, Enterprise Size, Form, Functionality, End User, and Geography
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 4,450 £Ü 6,427,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¾à¹°°¨½Ã ¹× ÀǾàǰ ¾ÈÀü¼º ¼ÒÇÁÆ®¿þ¾î ½ÃÀå(2024-2028³â)
Global Pharmacovigilance and Drug Safety Software Market 2024-2028
¹ßÇà 2024³â 08¿ù
°¡°Ý US $ 2,500 £Ü 3,610,000 (ºÎ°¡¼¼ º°µµ)
½ÃÆÇ ÈÄ ¾à¹°°¨½Ã ¹× ÀÇ·á Á¤º¸ ½ÃÀå º¸°í¼­ : À¯Çüº°, Á¦Ç°º°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2024-2032³â)
Post-marketing Pharmacovigilance and Medical Information Market Report by Type, Product, End User, and Region 2024-2032
¹ßÇà 2024³â 08¿ù
°¡°Ý US $ 2,999 £Ü 4,331,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¾à¹°°¨½Ã ½ÃÀå º¸°í¼­ : ¼­ºñ½º Á¦°ø¾÷üº°, Á¦Ç° ¼ö¸íÁֱ⺰, À¯Çüº°, °øÁ¤ È帧º°, Ä¡·á ¿µ¿ªº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°(2024-2032³â)
Pharmacovigilance Market Report by Service Provider, Product Life Cycle, Type, Process Flow, Therapeutic Area, End Use, and Region 2024-2032
¹ßÇà 2024³â 08¿ù
°¡°Ý US $ 2,999 £Ü 4,331,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¾à¹°°¨½Ã ½ÃÀå ±Ô¸ð Á¶»ç : À¯Çüº°, Àü°³º°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)
Global Pharmacovigilance Market Size Study, by Type (Service, Software), by Deployment (In-house, Outsource), by End User (Contract Research Organizations, Pharmaceutical & Biotechnology Companies, Others), and Regional Forecasts 2022-2032
¹ßÇà 2024³â 07¿ù
°¡°Ý US $ 4,950 £Ü 7,149,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¾à¹°°¨½Ã(PV) ½ÃÀå : ½ÃÀå ºÐ¼®°ú ¿¹Ãø(-2033³â) - À¯Çüº°, Á¦Ç°º°, ¼­ºñ½ºº°, ±â¼úº°, ÄÄÆ÷³ÍÆ®º°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, ¸ðµâº°, ±â´Éº°, Àü°³º°, Áö¿ªº°
Pharmacovigilance (PV) Market Analysis and Forecast to 2033: Type, Product, Services, Technology, Component, Application, End User, Module, Functionality, Deployment
¹ßÇà 2024³â 07¿ù
°¡°Ý US $ 4,750 £Ü 6,860,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀǾàǰ °¡°Ý Á¶»ç Åø ½ÃÀå : ½ÃÀå Á¡À¯À² ºÐ¼®, »ê¾÷ µ¿Çâ ¹× Åë°è, ¼ºÀå ¿¹Ãø(2024-2029³â)
Pharma Pricing Research Tools - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
¹ßÇà 2024³â 07¿ù
°¡°Ý US $ 4,750 £Ü 6,860,000 (ºÎ°¡¼¼ º°µµ)
ÀÇ·áºñ ȯ±Þ ½ÃÀå : û±¸±Ý¾×º°, ÁöºÒÀÚº°, ¼­ºñ½º Á¦°ø¾÷üº°, Áö¿ªº°
Healthcare Reimbursement Market, By Claim, By Payer, By Service Provider, By Geography
¹ßÇà 2024³â 07¿ù
°¡°Ý US $ 4,500 £Ü 6,499,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¾à¹°°¨½Ã ¹× ÀǾàǰ ¾ÈÀü¼º ¼ÒÇÁÆ®¿þ¾î ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)
Global Pharmacovigilance and Drug Safety Software Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
¹ßÇà 2024³â 07¿ù
°¡°Ý US $ 3,920 £Ü 5,661,000 (ºÎ°¡¼¼ º°µµ)
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.